Clinical Trial Detail

NCT ID NCT00996385
Title Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Columbia University
Indications

malignant pleural mesothelioma

peritoneal mesothelioma

Therapies

Bortezomib + Oxaliplatin

Age Groups: adult

No variant requirements are available.